The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin

被引:21
作者
Helgadottir, Holmfridur [1 ]
Metz, David C. [2 ]
Yang, Yu-Xiao [2 ]
Rhim, Andrew D. [2 ]
Bjornsson, Einar S. [3 ]
机构
[1] Univ Iceland, Fac Med, Reykjavik, Iceland
[2] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[3] Natl Univ Hosp Iceland, Dept Internal Med, Div Gastroenterol & Hepatol, Reykjavik, Iceland
基金
美国国家卫生研究院;
关键词
Dyspepsia; Gastrin; GERD; Proton-pump inhibitors; PLACEBO-CONTROLLED TRIAL; SERUM CHROMOGRANIN-A; HELICOBACTER-PYLORI; DOUBLE-BLIND; ANTIBODIES; SYMPTOMS; DISCONTINUATION; ESOPHAGITIS; OMEPRAZOLE; MANAGEMENT;
D O I
10.1016/j.dld.2013.09.021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background: Dyspepsia develops in healthy volunteers after withdrawal of proton-pump inhibitors. This phenomenon, attributed to rebound acid hypersecretion, is thought to be mediated by reflex hypergastrinemia. Aims: To measure fasting and postprandial gastrin in patients on long-term proton-pump inhibitor treatment and correlate gastrin levels with the duration of treatment and other potential predictors. Methods: In this cross sectional study patients, with erosive esophagitis, on long-term proton-pump inhibitor treatment and healthy controls underwent gastrin measurements at baseline and four times following a meal and Helicobacter pylori status was determined. Results: A total of 100 patients and 50 controls were studied. Pre- and postprandial gastrin levels were higher in patients (p < 0.001). No significant correlation was found between the area under the gastrin-curve and the treatment duration. Female patients had significantly higher gastrin levels than males pre- and postprandial, whereas such differences was not found in the control group. Female gender was the only independent predictor of s-gastrin levels (OR 2.50 compared to males, 95% CI: 1.08-5.76, p = 0.032) in the patient group. Conclusion: Gastrin values were higher in patients compared to controls. There was no correlation between gastrin levels and treatment duration. Female patients had significantly higher gastrin values than males. (C) 2013 Editrice Gastroenterologica Italiana S.r l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 30 条
[1]
ARCHIMANDRITIS A, 1979, ACTA HEPATO-GASTRO, V26, P58
[2]
Discontinuation of proton pump inhibitors in patients on long-term therapy:: a double-blind, placebo-controlled trial [J].
Bjornsson, E. ;
Abrahamsson, H. ;
Simren, M. ;
Mattsson, N. ;
Jensen, C. ;
Agerforz, P. ;
Kilander, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (06) :945-954
[3]
Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease [J].
Brunner, G. ;
Athmann, C. ;
Schneider, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (01) :37-47
[4]
Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion [J].
Cui, Guanglin ;
Waldum, Helge L. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (04) :493-496
[5]
Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms? [J].
Farup, PG ;
Juul-Hansen, PH ;
Rydning, A .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) :206-209
[6]
FELDMAN M, 1983, J CLIN INVEST, V71, P715, DOI 10.1172/JCI110818
[7]
Gedde-Dahl D, 1974, SCAND J GASTROENTERO, V9, P41
[8]
Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis [J].
Hegedus, O ;
Rydén, J ;
Rehnberg, AS ;
Nilsson, S ;
Hellström, PM .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (05) :513-520
[9]
Step-down from multiple- to single-dose proton pump inhibitors (PPIs): A prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs [J].
Inadomi, JM ;
McIntyre, L ;
Bernard, L ;
Fendrick, AM .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (09) :1940-1944
[10]
EFFECT OF LONG-TERM TREATMENT WITH OMEPRAZOLE ON SERUM GASTRIN AND SERUM GROUP-A AND GROUP-C PEPSINOGENS IN PATIENTS WITH REFLUX ESOPHAGITIS [J].
JANSEN, JBMJ ;
KLINKENBERGKNOL, EC ;
MEUWISSEN, SGM ;
DEBRUIJNE, JW ;
FESTEN, HPM ;
SNEL, P ;
LUCKERS, AEG ;
BIEMOND, I ;
LAMERS, CBHW .
GASTROENTEROLOGY, 1990, 99 (03) :621-628